Simultaneous alteration of residues 279 and 284 of the VP2 major capsid protein of a very virulent Infectious Bursal Disease Virus (vvIBDV) strain did not lead to attenuation in chickens by unknown
Abdeljelil et al. Virology Journal 2014, 11:199
http://www.virologyj.com/content/11/1/199RESEARCH Open AccessSimultaneous alteration of residues 279 and 284
of the VP2 major capsid protein of a very virulent
Infectious Bursal Disease Virus (vvIBDV) strain did
not lead to attenuation in chickens
Nawel Ben Abdeljelil1, Neila Khabouchi1, Selma Kassar2, Khaled Miled3, Samir Boubaker2, Abdeljelil Ghram3
and Helmi Mardassi1*Abstract
Background: Cell culture adaptation of very virulent infectious bursal disease virus (vvIBDV) was shown to be
mainly associated with the VP2 capsid protein residues 253, 279, and 284. The single mutation A284T proved critical
for cell culture tropism, but did not confer efficient virus replication, which at least required one additional
mutation, Q253H or D279N. While the double mutation Q253H/A284T was unambiguously shown to confer both
efficient replication in cell culture and attenuation in chickens, conflicting results have been reported regarding the
replication efficiency of vvIBDV mutants bearing the D279N/A284T double mutation, and no data are hitherto
available on their virulence in chickens.
Findings: Here we used an in vivo reverse genetics system to assess the impact of the D279N/A284T double mutation
on the replication and attenuation of a chimeric IBDV virus, whose polyprotein derived from a non-culturable vvIBDV
clinical isolate. We found that the D279N/A284T double mutation did indeed confer efficient replication in chicken
embryo fibroblast (CEF) cell culture, but the mutant virus remained highly pathogenic to chickens.
Conclusions: The double mutation D279N/A284T of the VP2 major capsid protein of vvIBDV is sufficient to confer cell
culture tropism and replication efficiency, but does not necessarily lead to virus attenuation.
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Infectious bursal disease virus (IBDV), a member of the
family Birnaviridae, genus Avibirnavirus, is the causative
agent of an avian restricted disease known as “Gumboro
disease” [1]. The virus causes severe immunodepression
in young chicken by destruction of B cells and finally the
bursa of Fabricius [2]. These infected immunodepressed
chickens become highly susceptible to secondary infec-
tions and have a reduced capacity to respond to vaccin-
ation [3-5]. IBDV is therefore a major economic issue
for the poultry industry. Protection of susceptible flocks* Correspondence: helmi.merdassi@pasteur.rns.tn
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article, unless otherwise stated.is achieved by vaccination against IBDV using either
attenuated live or inactivated virus [6].
The genome of IBDV consists of two segments of
double-stranded RNA (dsRNA), referred to as segments A
and B [7,8]. The smaller segment B (2.8 kbp) harbours a
single open reading frame (ORF) encoding VP1, a protein
with an RNA-dependent RNA polymerase and capping
enzyme activities [9-11]. Genome segment A (3.2 kbp)
contains two overlapping ORFs. The first smallest ORF
encodes VP5, a 17-kDa non structural protein, while
the second ORF codes for the precursor polyprotein
NH2-pVP2-VP4-VP3-COOH [12,13]. This polyprotein
is co-translationally self-cleaved, yielding ultimately the
capsid protein VP2, the viral protease VP4, and the
multifunctional scaffolding nucleocapsid VP3 [14-16].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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[17]. Wild-type isolates belonging to serotype 1 are patho-
genic for chickens, while serotype 2 isolates, which are
mainly recovered from turkeys, are regarded as non
pathogenic for chickens [18,19]. IBDV serotype I includes
four pathotypes, namely attenuated, classical virulent,
antigenic variant, and very virulent (vvIBDV). The latter
pathotype has emerged in Europe since the mid 1980s,
and was since reported worlwide as the deadliest patho-
type, with 60–100% mortality in chickens [20-25].
Early studies using site-directed mutagenesis coupled
with reverse genetics showed that capsid VP2 amino acid
residues at positions 253, 279, and 284, are involved in cell
culture adaptation and/or virulence of vvIBDV [26-30].
More recently, the contribution of residues 249 and 265
was reported [31]. It was shown that simultaneous alter-
ation of residues 253 (Q to H) and 284 (A to T) confers cell
culture tropism and efficient replication in chicken embryo
fibroblast (CEF) cells, but neither of the two mutations
could do so when introduced individually [27,28]. Accord-
ing to the same independent studies, the attenuating
phenotype of the double exchange Q253H and A284T was
unambiguously demonstrated. It has also been shown that
the double mutation D279N and A284T results in cell cul-
ture adaptation of the vvIBDV strain HK46, which grew to
high titers [29]. This finding could not be confirmed with
vvIBDV strain UK661, since the molecularly engineered
virus bearing the double mutation D279N/A284T yielded
very low titers compared to that bearing the double
exchange Q253H/A284T [28]. Furthermore, with both
HK46 and UK661 strains, the impact on virulence of the
double mutation D279N/A284T has not been explored.
Here using a chimeric virus generated by in vivo
reverse genetics, we show that the double exchange
D279N/A284T in the VP2 sequence of vvIBDV indeed
confers efficient replication in CEF cells, but could not
attenuate the rescued chimeric virus in chickens.
Materials and methods
Cells
Primary Chicken Embryo Fibroblast (CEF) cells were
freshly prepared from 9 to 11-day-old-embryonated spe-
cific pathogen-free (SPF) eggs. The cells were grown in
Dulbecco’s minimal essential medium (DMEM) supple-
mented with 10% foetal bovine serum (FBS) at 37°C in a
humidified 5% CO2 incubator. CEF cells were used for
transfections, virus propagation and tittering.
Plasmid constructs
Plasmid constructs pVAXSA.Rib and pVAXSB.Rib
[32,33] contain the full-length cDNA sequence of the
cell culture-adapted and attenuated P2 strain segments
A and B, respectively [34]. In both constructs, the 5′ end
of each genomic segment was fused to the transcriptionstart site of the immediate early CMV promoter, while a
hepatitis delta virus (HDV) ribozyme sequence was added
at the 3′ end. This cloning strategy was designed so that
the host RNA polymerase II will produce segments A and
B transcripts with authentic 5′ and 3′ termini; an in vivo
reverse strategy which has significantly improved the titer
of rescued IBDV [32].
Construction of chimeric and mutant infectious IBDV
cDNA clones
The full-length coding sequence of the polyprotein and
the 3′ non-coding region of PO7, a Tunisian bursal-
derived field isolate of vvIBDV [35], was amplified by PCR
using the primer pair IB2SP1/SAR1 (Table 1) and the
Expand High Fidelity Taq polymerase mix (Roche Applied
Science, Germany). The resulting amplicon was cloned into
kpnI/EcoRI-restricted pCR2.1 plasmid vector (Invitrogen),
yielding the construct pCR.PO7poly.wt. This was next used
as template to substitute the VP2 amino acid residues
aspartic acid (D) to asparagine (N), and alanine (A) to
threonine (T), at positions 279 and 284, respectively.
Site-directed mutagenesis was carried out by overlap
extension using PCR [36]. Briefly, two independent
PCR reactions were performed using the primer pairs
IB2SP1/MutR and MutS/SAR2. MutR and MutS are
the mutagenic overlapping primers (Table 1). The two
PCR products were combined, denatured, annealed,
and subjected to 3′ extension followed by a fusion PCR
amplification using the external primer pair IB2SP1/
SAR2. The resulting PCR product was restricted with
KpnI/SalI and subcloned into the similarly digested
pCR.PO7poly.wt plasmid, yielding pCR.PO7poly.mt.
Effective incorporation of the nucleotide changes was
confirmed by DNA sequencing.
Next, pCR.PO7poly.wt was restricted with BspEI/EcoRI
and subcloned into BspEI/EcoRI-digested pVAXSA.Rib.
Since EcoRI digestion of pVAXSA.Rib eliminates the HDV
ribozyme sequence, the latter was restored at the 3′ end
of PO7 segment A, using the same previously described
strategy [32]. The resulting plasmid construct, pVAXSA.
PO7wt.Rib (Figure 1), contains a full-length chimeric
segment A cDNA sequence where the 5′ end first 215
nucleotides originated from the attenuated P2 strain, while
the remaining sequence (216 to 3261) derived from the
Tunisian PO7 vvIBDV strain.
Finally, the plasmid pCR.PO7poly.mt was cleaved with
BspEI/SalI and inserted into the corresponding restriction
sites of pVAXSA.PO7wt.Rib, yielding pVAXSA.PO7mt.
Rib, which contains the double mutation D279N/A284T
in the PO7 VP2 capsid sequence (Figure 1).
Rescue of IBDV via in vivo reverse genetics
To rescue chimeric IBDV virus expressing the wild-type
or the D279N/A284T mutated PO7 polyprotein, 5 μg
Table 1 Primers used in PCR amplifications, cloning and mutagenesis of IBDV segments A and B
Primer designation Sequence (5′-3′) Orientation Location Restriction site
IB2SP1 CATGGTACCATGACAAACCTGCAAGATCAAACC + 131-154 KpnI
SAR1 AGAGAATTCAGGGGACCCGCGAACGGATCCAATT - 3237-3261 EcoRI
MutS GCAAACAATGGGCTAACGACCGGCACTGACAACC - 962-995 -
MutR GGTCGTTAGCCCATTGTTTGCGGCCACAGCTCTG - 949-982 -
SAR2 CAAGAATCCCGTCGACTACG - 1739-1720 SalI
SAS1 GGATACGATCGGTCTGACCC + 1-20 -
SBS1 GGATACGATGGGTCTGACCC + 1-20 -
SBR1 GGGGCCCCCGCAGGCGAAGG - 2826-2807 -
Restriction enzyme sites are italicized.
Nucleotides used for mutagenesis of VP2 residues 279 and 284 are indicated in bold.
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pVAXSA.PO7mt.Rib were cotransfected with the same
amount of pVAXSB.Rib. For comparative purposes,
pVAXSA.Rib and pVAXSB.Rib plasmid constructs were
cotransfected in parallel in order to rescue the cell
culture-adapted and attenuated P2 strain, as previously
described [32]. Co-transfections of CEF cells growing at
80% confluence in 100-mm culture dishes were performed
using FuGENE-6, according to the manufacturer’s proto-
col (Roche Applied Science). At 3 days post-transfection,
while cytopathic effect was evident, the supernatant was
collected, clarified by low-speed centrifugation, aliquoted
and then frozen at −70°C. This original unpassaged virus
stock (P0) was further subjected to two consecutive
passages (P1 and P2). The titers of the original virus stock














SA: Segment A 
SB: Segment B 
Figure 1 Schematic representation of IBDV segments A and B infectioupon three independent assays on CEF cells and expressed
as TCID50/ml (Tissue Culture Infectious Dose 50).Evaluation of the rescued IBDV virus pathogenicity in
chickens
Three-week-old specific-pathogen-free (SPF) chicks were
used. A group of 30 chickens were raised in isolators
with filtered air-flow and randomly divided into three
groups of 10 chicks each. Prior to inoculation, chickens
were checked for seronegativity to IBDV. To minimize
the risk that viruses used to infect chickens may contain
undesired mutations in either genomic segment, only
the unpassaged (P0) virus stock (the supernatant of
cotransfected CEF cells) of the rescued viruses was used.








us cDNA constructs used in the present study.
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saline (PBS), by eye drop.
Clinical signs were determined using a newly devel-
oped symptomatic index score (0 to 3) as described in
Nouen et al. [37]. Chickens were humanely euthanized
at day 10 post-inoculation. Bursas and spleens were
removed, weighed, and the mean organ/body weight (BW)
ratio was determined according to Ismail and Saif [38] using
the following formula: organ weight in grams × 1000)/BW
in grams.
Organs were split into two parts. One part was used to
extract total RNA, and the second part was processed
for histopathology.
Determination of the nucleotide sequence of the genomic
segments A and B of IBDV recovered from the bursas of
infected chicks
Bursas were cut into small pieces, ground with sterile
sea sand in PBS, and the homogenates were centrifuged
at full-speed in an eppendorf centrifuge for 10 min
at +4°C. RNA was extracted using the QIAmp viral RNA
mini kit (Qiagen) following the manufacturer’s instruc-
tions. RT-PCR amplifications were performed using the
Qiagen OneStep RT-PCR-Kit (Qiagen), essentially as
recommended by the supplier, using segment-specific
primer pairs SAS1/SAR1 and SBS1/SBR1 (Table 1). PCR
products were cloned into pCR2.1 plasmid vector and
subjected to nucleotide sequencing using additional
sense and reverse primers. The full-length sequence of
both segments was determined with the exception of the
first and last 20 nucleotides (primer binding sites). For
each segment, the nucleotide sequence was confirmed
twice.
Histopathological examination
Formalin-fixed bursa were embedded with paraffin, sec-
tioned and stained with haematoxylin/eosin following
standard procedures. Depending on the severity of bur-
sal follicular necrosis, bursal lesions were assigned the
score (BLS) of 0 (normal), 1 (mild lymphoid depletion
with absence of necrosis/oedema), 2 (moderate lymphoid
depletion along with focal necrosis and interfollicular
oedema), 3 (severe lymphoid depletion virtually leaving
no lymphocyte but only reticular cells and proliferating
fibrous tissue, or 4 (atrophy of follicles usually with
cystic spaces, infolding of epithelium and marked
fibroplasias).
Statistical analysis
Statistics were calculated using Prism software (GraphPad
Software Inc.). The data were presented as the means and
evaluated by one-way ANOVA followed by Newman-
Keuls multiple comparison test. For comparison of virustiters, the unpaired t test was used. The level of significance
was P <0.05.
Results
In vivo reverse genetics mediated recovery and
replication efficiency in CEF cells of IBDV specifying the
polyprotein sequence of PO7, a Tunisian vvIBDV strain
Using as recipient hosts infectious clones pVAXSA.Rib
and pVAXSB.Rib of the cell culture-adapted and atten-
uated IBDV P2 strain, we attempted to rescue in CEF
cells IBDV virus specifying the polyprotein sequence of
the Tunisian bursal-derived vvIBDV PO7 strain [35].
The VP2 amino acid residues at positions 253 (Q), 279
(D), and 284 (A) of the wild-type PO7 strain corre-
sponded to those of non culturable vvIBDV strains. For
this purpose, we exchanged the P2 segment A se-
quence extending from the natural BspEI restriction
site (nucleotide position 215) to the 3′ end ultimate
nucleotide with its corresponding sequence of the
wild-type Tunisian PO7 vvIBDV strain. With this cloning
strategy, the entire polyprotein amino acid sequence spe-
cified by this chimeric P2/PO7 segment A is identical to
that of the wild-type PO7 strain, and differs from the seg-
ment A cDNA infectious clone of the P2 strain by 19
amino acid residues (P222A, V242I, R249Q, H253Q,
I255L, V256I, N279D, T284A, L294I, N299S, R330S,
I451L, V541I, K685N, P715S, H751D, D918E, L981P, and
T1005A) (Figure 2). As previously shown, the IBDV P2
strain which bears the VP2 amino acids H253, N279, and
T284, common to all tissue-culture-adapted IBDV strains,
was readily rescued when CEF cells were co-transfected
with pVAXSA.Rib and pVAXSB.Rib plasmid constructs
[32]. Indeed, cytopathic effect typical of IBDV replication
could be observed as soon as three days post-transfection,
and was successfully passaged twice, using the supernatant
of transfected cells. No cytopathic effect could be ob-
served when the chimeric P2/PO7 segment A harbouring
the wild-type PO7 polyprotein sequence (bearing the
amino acid combination Q253, D279, and A284) was used
in co-transfection experiments (pVAXSA.PO7wt.Rib and
pVAXSB.Rib), and no signs of virus replication could be
detected even after three successive passages (data not
shown). By contrast, when the segment A infectious
cDNA clone bearing the double mutation D279N/A284T
in the PO7 polyprotein sequence (pVAXSA.PO7mt.Rib)
was used in cotransfections, a cytopathic effect was appar-
ent and could be passaged twice. Upon cotransfections,
the rescued chimeric mutated P2/PO7 (P2/PO7mt; bear-
ing the amino acid combination Q253, N279, and T284)
and P2 viruses yielded nearly equivalent titers, varying
from 107 to 108.5 TCID50/ml. Through passages 1 and 2,
the P2/PO7mt virus displayed approximately 0.5 log
higher titers than P2, but these differences in titers was
not statistically significant (P = 0.266) (Figure 3).
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PO7wt   MTNLQDQTQQIVPFIRSLLMPTTGPASIPDDTLEKHTLRSETSTYNLTVGDTGSGLIVFFPGFPGSIVGAHYTLQSNGNYKFDQMLLTAQNLPASYNYCRLVSRSLTVRSSTLPGGVYALNGTINAVTFQ
P2/PO7mt ..................................................................................................................................
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OKYMT   .............................................................................................................................T....
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P2/PO7mt ..................................................................................................................................
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OKYMT   ..................................................................................................................................
530       540       550       560       570       580       590       600       610       620       630       640       650  
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
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P2/PO7mt ..................................................................................................................................
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P2/PO7mt ......................................................................................................
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OKYMT   ......................................................................................................
Figure 2 Amino acid sequence alignment of the polyprotein sequences of the Tunisian vvIBDV wild-type PO7 strain (PO7wt), the cell
culture-adapted and attenuated P2 and OKYMT IBDV strains, and the cell culture-adapted, but virulent, D279N/A284T mutated P2/PO7
chimeric IBDV virus (P2/PO7mt). Amino acid residues (positions 253, 279, and 284) known to be involved in cell culture adaptation and
virulence are highlighted in green. The residue 256 which could have contributed to OKYMT attenuation is highlighted in orange.
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P2/PO7 IBDV in SPF chickens
Chickens inoculated by eye drop with 105 TCID50 of
unpassaged P2/PO7mt virus stocks (using the super-
natant of CEF transfected cells) showed typical clinical
symptoms of vvIBDV infection. Nine of ten chickens
(90%) died in the first 3 days post-inoculation. The
bursa/body and spleen/body weight ratios (B/BW and S/
BW, respectively) were significantly lower than in nor-
mal chickens (P <0.05; one-way ANOVA followed by
Newman-Keuls multiple comparison test) (Table 2). By
contrast, none of the P2-inoculated chickens showed typical
clinical signs of vvIBDV infection during the whole 10-day
observation period, and all chickens of this group survived.
The bursa/body and spleen/body weight ratios were not
significantly different from normal chickens (P >0.05).
Histopathological examination of the bursa
All bursae of dead chicks inoculated with the resuced P2/
PO7mt IBDV virus showed severe necrosis, atrophy, and
loss of the follicular architecture. By contrast, histopatho-
logic sections of bursa derived from control (inoculatedwith PBS) or P2-infected chicks were similar and had
normal follicles and follicular connective tissues (Figure 4).
These results clearly indicate that the molecularly engi-
neered cell culture-adapted P2/PO7mt IBDV was not
attenuated in chickens.
Sequence analysis of segments A and B extracted from
the bursae of dead chicks
Sequence analysis of both genomic segments of the
rescued P2/PO7mt virus from the bursa of Fabricius of
dead chicks did not reveal any amino acid change (data
not shown).
Discussion
Previously we reported the nucleotide sequence of the
VP2 hypervariable region of bursal-derived Tunisian
vvIBDV field isolates and the polyprotein coding se-
quence of PO7, a Tunisian vvIBDV representative isolate
[35]. This strain was recovered from the bursa of dead
chickens from a Tunisian layer flock that have experi-
enced a severe outbreak with nearly 100% motality.
Experimental inoculation of SPF chicks with the original
P2/PO7mt P2 
P0 8,25 8,50 8,75 8,25 8,50 8,50
P1 7,75 8,50 8,00 7,00 7,25 7,75





Figure 3 Titers in CEF cells of the rescued P2 and P2/PO7mt molecularly engineered IBDV viruses. The table on top shows the titers
(in TCID50/ml) of the rescued viruses obtained after three independent titering assays from cotransfected CEF cells (P0), and after two sucessives
passages (P1 and P2). The corresponding graph is shown on bottom.
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birds in the first three days. Birds that succumbed to in-
fection showed inappetence and diarrhea. Autopsy of dead
chicks showed mainly haemorrhagic and atrophied bursa,
as well as petechial haemorrhages on the mucosa and in
muscular tissues. The very virulent pathotype of the
Tunisian PO7 strain was further confirmed molecularly,
giving the presence of the four amino acid residues, A222,
I256, I294, and S299 in the hypervariable region of its VP2
sequence [35].
Several attempts to adapt the PO7 isolate to cell cultures
proved unsuccessful. This result was congruent with the na-
ture of its VP2 amino acid residues at positions 253 (Q), 279
(D), and 284 (A). Using an in vivo reverse genetics approach
that we have previously developed in our laboratory [32,33],Table 2 Pathogenicity of the rescued P2 and P2/PO7
molecularly engineered IBDV viruses in SPF chicken
Virus Groupa Scoreb B/BW ratioc S/BW ratiod Deade
P2/PO7 1 3 2.936 1.834 9/10
P2 2 0 4.788 1.959 0/10
- Control 0 7.024 2.041 0/10
aGroups of 10 SPF chickens each were inoculated at the age of 3 weeks with
either P2 virus or P2/PO7 mutant virus collected from the supernatant of
transfected CEF cells. Chickens in the control group were inoculated with PBS.
bScore 0: no damage; score 1: mild damage; score 2: moderate damage; score
3: severe damage.
cB/BW: (average bursa in grams · 1000)/total body weight in grams. Values
show the averages for 10 chickens.
dS/BW, (average spleen in grams · 1000)/total body weight in grams. Values
show the averages for 10 chickens.
eNumber of dead chickens at 3 days post-inoculation.we constructed a chimeric IBDV infectious clone whose
polyprotein derived from the Tunisian vvIBDV PO7 strain,
using segments A and B infectious cDNA backbones of
strain P2, a tissue culture-adapted and attenuated German
IBDV strain.
The finding that the double exchange D279N/A284T
yielded a high-titer virus further confirmed the results of
Lim et al. [29], in that the two amino acid residues N279
and T284 are sufficient to confer cell culture adaptation.
The inability to obtain high-titer virus with the vvIBDV
UK661 bearing the same residues may stem from differ-
ences in the strain’s genetic background, or could be due
to the approach of reverse genetics that has been used
[28]. Indeed, Lim et al. [29] used an in vivo reverse gen-
etics method, which could have contributed to rescue
high-titer virus. We also used in vivo reverse genetics,
but unlike the approach of Lim et al. [29], our method
has been conceived to generate genomic transcripts with
authentic 5′ and 3′ ends [32], which is likely to be the
main feature that allowed us to rescue high-titer chimeric
P2/PO7 mutated virus.
The data obtained in this study demonstrate, for the first
time, that acquisition of cell culture tropism by IBDV was
not accompanied with its attenuation in chickens. The
D279N/A284T double exchange in the VP2 capsid protein
proved sufficient to confer cell culture adaptation and
replication efficiency but did not lead to attenuation. This
finding is in agreement with the study previously reported
by Raue et al. [39]. Indeed, they noticed that reversion of




Figure 4 Histopathological appearance of hematoxylin/eosin sections of bursa. Note the severe necrosis, atrophy, and loss of the follicular
architecture in sections derived from bursa of P2/PO7-infected chickens. By contrast, histopathologic sections of bursa derived from the control or P2-
infected chikens showed normal follicles and follicular connective tissues.
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full recovery of which was concomitant with reversion of
the H253 residue to the wild-type (Q253), which occurred
10 to 11 days after. Sequencing of segments A and B of
the culture-adapted, but virulent, P2/PO7mt virus recov-
ered from the bursa of dead chickens showed no new
mutations and confirmed the presence of the virulence-
associated Q residue at position 253, as well as the conser-
vation of N279 and T284 residues. As mentioned above,
in our study we infected chickens with unpassaged virus
stocks (using the supernatant of transfected cells); there-
fore, we minimized the risk to generate new spontan-
eous mutations that might change the phenotype of the
rescued mutant virus. Consistent with our sequencing
results is the fact that P2/PO7mt virus recovered from
dead chickens can still be propagated in cell culture.
However, the finding that the cell culture-adapted P2/
PO7 mutant virus remained pathogenic contrasts with the
attenuated nature of strain OKYMT [40], which like P2/
PO7mt displays the amino acid combination Q253, N279,
and T284 (Figure 2). Comparative sequence analysis
revealed that OKYMT differed from the mutant P2/PO7
virus at the three amino acid positions, 256, 315, and 805
(Figure 2). Strikingly, the amino acid residue at position
256 has been reported to be involved in the replication ef-
ficiency and virulence of IBDV [31]. Indeed, a mutant
IBDV whose Isoleucine residue at position 256 was chan-
ged to Valine proved less virulent. Unlike P2/PO7mt virus,
which bears an Isoleucine residue at position 256 (I256),
the attenuated OKYMT strain shows a Threonine at the
same position (T256). Hence, one can wrightfully argue
that the T256 residue could have contributed to OKYMT
attenuation. However, one should not dismiss the possibil-
ity that amino acid positions 315 and, to a lesser extent,805 could have further attenuated OKYMT strain. More-
over, attenuation of OKYMT involved 43 successive pas-
sages (20 passages in chorioallantoic membrane, 15 in
yolk sac, and 8 in CEF cells), which could have resulted in
the accumulation of attenuating mutations in the poly-
merase VP1 gene encoded by segment B. Indeed, it is now
well established that segment B contributes to the viru-
lence of vvIBDV [41-43]. It has been shown that a single
change in VP1 sequence contributes even more to attenu-
ation than a substitution in the polyprotein sequence [41].
Consistent with this finding, it was shown that a Valine to
Isoleucine substitution in VP1 at amino acid position 4
attenuates vvIBDV in chickens, but increased its replica-
tion in CEF cells [42]. Sequence comparison of VP1 genes
of P2 (specified by our chimeric P2/PO7mt virus) and the
attenuated OKYMT would provide a more thorough ana-
lysis. Unfortunately, only the segment A sequence of
OKYMT has been published hitherto.
Conclusions
Based on the work described here, we conclude that the
double mutation D279N/A284T of the VP2 major capsid
protein of vvIBDV is sufficient to confer cell culture
adaptability and replication efficiency, but it does not
necessarily lead to virus attenuation.
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